Estrogen receptor beta expression in prostate adenocarcinoma

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Prostate cancer is a leading cause of cancer death in men.
• Estrogen influences prostate cancer growth, with estrogen receptor beta (ER-b) playing a key role in signaling pathways.
• Understanding ER-b expression is crucial for elucidating prostate cancer mechanisms.

Purpose of the Study:

• To investigate the expression of estrogen receptor beta (ER-b) in human prostate cancer tissues.
• To determine the frequency and rate of ER-b expression across different Gleason grades of prostate adenocarcinoma.

Main Methods:

• A cross-sectional study of 52 prostate needle biopsy samples.
• Immunohistochemical staining using a monoclonal anti-ER-b antibody and an Envision visualization system.
• Analysis of ER-b expression in relation to Gleason grading.

Main Results:

• ER-b expression was observed in 100% of low and intermediate grade tumors (29 cases).
• ER-b expression was present in 83% of high-grade tumors (19 out of 23 cases).
• Mean ER-b expression rate was 68.41% in low/intermediate grades versus 49.48% in high-grade cancers.

Conclusions:

• Estrogen receptor beta (ER-b) expression is significantly reduced in high-grade prostate cancers compared to low and intermediate-grade tumors.
• This reduction in ER-b expression in advanced prostate cancer warrants further investigation.
• The findings suggest a potential role for ER-b in prostate cancer progression.